IMTX today
$6.52-$0.17 (-2.54%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourDescending Triangle
1 hourStrong Bullish
15 minLeaning Bullish
5 minSymmetric Triangle
Daily trend turns up above $7.95
Key levels
Resistance$7.52
Resistance$7.00
Support$6.09
Support$5.55
Latest news & SEC filings
AnalystStifel started coverage of Immatics (IMTX) with a Buy rating and a price target of $15.
All IMTX news →About Immatics
Immatics is a clinical-stage biopharmaceutical company that discovers and develops T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes engineered T cell therapies and antibody-like TCR bispecifics designed to target tumor antigens. The company works with pharmaceutical partners and academic collaborators on clinical development and commercialization. It operates research and manufacturing facilities in Germany and the United States.
Based on the company's 20-F filed Mar 5, 2026.
Nasdaq · Healthcare
Immatics N.V. (IMTX)
What Is the Price Target for IMTX?
SEPT Low Target
$15.00
SEPT Mid Target
$15.00
SEPT High Target
$15.00
Analyst Consensus
$15.00
Is IMTX a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IMTX.
Start Free Trial →Is IMTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$15.00
0
Moat Score
NONE
2/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with IMTX?
Insider Signal
NEUTRAL
1 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | director | Buy | 863,060 | $7.5M | Aug 26, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →IMTX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-1300%
FCF Growth YoY
-9.6%
Revenue Trend
UNKNOWN
Dark Pool Trades for IMTX
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for IMTX, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:31:57 | $6.52 | 19,786 | $$129K | BUY |
| 22:31:45 | $6.52 | 3,577 | $$23K | BUY |
| 22:12:15 | $6.52 | 23,364 | $$152K | SELL |
| 21:00:25 | $6.52 | 2,114 | $$14K | SELL |
| 21:00:25 | $6.52 | 4,800 | $$31K | SELL |
5 dark pool trades shown · $$350K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Immatics N.V. (IMTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →IMTX — frequently asked questions
What is IMTX stock price today?
Immatics N.V. (IMTX) is at $6.52, down 2.54% (-$0.17) at the Nov 12, 2026 close.
Why is IMTX stock moving today?
Latest IMTX news — Oct 14, 2026: Stifel started coverage of Immatics (IMTX) with a Buy rating and a price target of $15.
What is the IMTX price target?
The average analyst price target for IMTX is $15.00, ranging from $15 to $15, based on 1 analysts. Latest: Stifel initiates on Oct 14, 2026.
What do analysts rate IMTX?
Analyst ratings for IMTX: 2 Buy, 0 Hold, 0 Sell — consensus Buy.
Did IMTX beat earnings?
IMTX last reported on Aug 18, 2026: EPS -$0.53 vs -$0.48 expected — a miss of 10.5%.
Does IMTX pay a dividend?
IMTX does not currently pay a dividend.
What are IMTX support and resistance levels?
Support: $6.09, $5.55, $5.05. Resistance: $7.00, $7.52, $8.06.
What are insiders doing with IMTX?
Insider activity: NEUTRAL, 1 buys and 0 sells in the last 90 days.
What is the latest news on IMTX?
Oct 14, 2026: Stifel started coverage of Immatics (IMTX) with a Buy rating and a price target of $15.